Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected RecipientsChristine M. Durand, Niraj M. Desai, Mary G. Bowring et al.|Annals of Internal Medicine|2018Cited by 295
The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United StatesChristine M. Durand, Dorry L. Segev, Mary G. Bowring et al.|Annals of Internal Medicine|2018Cited by 195
A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in actionChristine M. Durand, Dorry L. Segev, Yolanda Eby et al.|American Journal of Transplantation|2020Cited by 112
Changes in Utilization and Discard of Hepatitis C–Infected Donor Livers in the Recent EraMary G. Bowring, Christine M. Durand, Lauren M. Kucirka et al.|American Journal of Transplantation|2016Cited by 105
HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIVChristine M. Durand, Dorry L. Segev, Sander Florman et al.|American Journal of Transplantation|2021Cited by 80